Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease
Liver disease
DOI:
10.1152/ajpgi.00047.2024
Publication Date:
2024-04-16T15:23:30Z
AUTHORS (19)
ABSTRACT
Patients with autoimmune liver disease but without overt diabetes display glucose disturbances early on in their course. We identified pathophysiological traits specific to these patients including altered incretin responses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....